Try it
Pharmacology · GI drugs: antiemetics for chemotherapy
Sample itemA woman receiving cisplatin for ovarian cancer has severe delayed vomiting despite ondansetron. Which agent should be added to target the delayed phase through a different receptor?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
D. Aprepitant, an NK1 receptor antagonist
Delayed emesis after cisplatin is mediated substantially by substance P acting on NK1 receptors in the brainstem. Aprepitant, added to a 5-HT3 antagonist and dexamethasone, markedly improves control. Ondansetron also prolongs the QT interval, which is a safety consideration.
Option by option
A. Prochlorperazine
Prochlorperazine is a weaker option for highly emetogenic chemotherapy.
B. Metoclopramide at low dose only
Metoclopramide has modest benefit and is not first choice for delayed emesis.
C. Hyoscine
Hyoscine is used for motion sickness, not chemotherapy emesis.
D. Aprepitant, an NK1 receptor antagonist (correct)
Correct. NK1 blockade targets delayed emesis.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pharmacology questions
- Emergency drugsA patient develops stridor, wheeze and hypotension minutes after an injection. What is t…
- AntiepilepticsWhat is the preferred first-line drug for a patient in generalised convulsive status epi…
- AntimicrobialsWhich drug can cause a disulfiram-like reaction when taken with alcohol?
- AntiepilepticsWhich drug is preferred for uncomplicated childhood absence seizures?